|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C12N 15/113 | (2010.01) |
| (11) | Number of the document | 3329002 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16750567.6 |
| Date of filing the European patent application | 2016-07-28 | |
| (97) | Date of publication of the European application | 2018-06-06 |
| (45) | Date of publication and mention of the grant of the patent | 2020-10-07 |
| (46) | Date of publication of the claims translation | 2021-01-11 |
| (86) | Number | PCT/US2016/044359 |
| Date | 2016-07-28 |
| (87) | Number | WO 2017/023660 |
| Date | 2017-02-09 |
| (30) | Number | Date | Country code |
| 201562199563 P | 2015-07-31 | US | |
| 201662287518 P | 2016-01-27 | US |
| (72) |
ZIMMERMANN, Tracy, US
CHAN, Amy, US
JADHAV, Vasant, US
MAIER, Martin, US
RAJEEV, Kallanthottathil, G., US
|
| (73) |
Alnylam Pharmaceuticals, Inc.,
300 Third Street, 3rd Floor, Cambridge, MA 02142,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Transtiretino (TTR) iRNR kompozicijos ir jų naudojimo būdai, skirti naudoti su TTR susijusių ligų gydymui arba prevencijai |
| TRANSTHYRETIN (TTR) IRNA COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING OR PREVENTING TTR-ASSOCIATED DISEASES |
| Payment date | Validity (years) | Amount | |
| 2025-07-08 | 10 | 231.00 EUR |
| 2026-07-28 |